Notably, CN21 peptide inhibitor of CaMKII which inhibits post-stroke cell toxicity [2,3] not only interferes with formation of CaMKII/NMDAR complex in vitro [70] but also reduces the existing complex in living brain slices [71]. The gene discussed is CAMK2G; the disease is stroke disorder.